Risk factors, prevention and treatment of weight gain associated with the use of antidepressants and antipsychotics: a state-of-the-art clinical review.
抗憂鬱劑和抗精神病藥物使用相關體重增加的風險因素、預防及治療:一項最前沿的臨床綜述。
Expert Opin Drug Saf 2024-09-03
Effect of Glucagon-like Peptide-1 Receptor Agonists on Cardio-Metabolic Risk Factors among Obese/Overweight Individuals Treated with Antipsychotic Drug Classes: An Updated Systematic Review and Meta-Analysis of Randomized Controlled Trials.
「糖尿病樣肽-1 受體激動劑對接受抗精神病藥物治療的肥胖/超重個體心血管代謝風險因子的影響:一項最新的隨機對照試驗系統性回顧和荟萃分析。」
Biomedicines 2023-03-31
Antipsychotic-induced weight gain: exploring the role of psychiatrists in managing patients' physical health - challenges, current options and direction for future care.
抗精神病藥物誘發的體重增加:探討精神科醫師在管理患者身體健康中的角色 - 挑戰、目前選項和未來護理方向。
BJPsych Bull 2024-02-02
Glucagon-like peptide-1 receptor-agonists treatment for cardio-metabolic parameters in schizophrenia patients: a systematic review and meta-analysis.
精神分裂症患者的胰高血糖素樣肽-1受體激動劑治療:系統性回顧和荟萃分析。
Front Psychiatry 2023-05-23
Therapeutic management of atypical antipsychotic‑related metabolic dysfunctions using GLP‑1 receptor agonists: A systematic review.
非典型抗精神病藥物相關代謝功能障礙的治療管理:GLP-1 受體激動劑的系統性回顧。
Exp Ther Med 2023-06-19
Promising translatable pharmacological interventions for body weight management in individuals with severe mental illness - a narrative review.
嚴重精神疾病患者體重管理的有前途的可翻譯藥物干預 - 敘事性回顧。
Expert Opin Pharmacother 2023-11-02
Glucagon-like peptide agonists for weight management in antipsychotic-induced weight gain: A systematic review and meta-analysis.
抗精神病藥物引起的體重增加中,胰高血糖素樣肽激動劑對體重管理的系統性回顧與統合分析。
Acta Psychiatr Scand 2024-07-24